Sugi Predict

Sugi Predict / Compounds / SCHEMBL2988482

SCHEMBL2988482

SCHEMBL2988482

COC(OC)c1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(=O)O)s3)c2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 18/20 0.70
▸ PLK3 Q9H4B4 11/20 0.70
▸ NEK2 P51955 3/20 0.59
▸ PIK3CD O00329 2/20 0.59
▸ PDGFRB P09619 2/20 0.59
▸ PIM1 P11309 2/20 0.59
▸ PIK3CG P48736 2/20 0.59
▸ PIK3C2B O00750 1/20 0.59
▸ RIOK3 O14730 1/20 0.59
▸ DAPK3 O43293 1/20 0.59
▸ PIP5K1C O60331 1/20 0.59
▸ RPS6KA4 O75676 1/20 0.59
▸ STK10 O94804 1/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ KIT P10721 1/20 0.59
▸ CSNK2A2 P19784 1/20 0.59
▸ GRK4 P32298 1/20 0.59
▸ TIE1 P35590 1/20 0.59
▸ FLT3 P36888 1/20 0.59
▸ PRKCI P41743 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2982257 0.93 PLK1 (0.69) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2979873 0.89 PLK1 (0.67) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2986893 0.89 PLK1 (0.73) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2990382 0.88 PLK1 (0.72) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2988855 0.86 PLK1 (0.70) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2978893 0.86 PLK1 (0.70) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2988621 0.86 PLK1 (0.75) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL3615343 0.86 PLK1 (0.69) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2982107 0.86 PLK1 (0.69) PLK1PLK3NEK2PIK3CDPDGFRB
SCHEMBL2978876 0.86 PLK1 (0.69) PLK1PLK3NEK2PIK3CDPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786127-B2 Benzimidazole thiophene compounds Glaxo SmithKline LLC (US) 2010-08-31 — — US disclosed
US-7595330-B2 Benzimidazole thiophene compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-09-29 — — US disclosed
US-20090005398-A1 Methods For The Treatment of Central Nervous System Tumors SMITHKLINE BEECHAM CORPORATION 2009-01-01 — — US disclosed
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes SMITHKLINE BEECHAM CORPORATION 2008-10-09 — — US disclosed
US-20080214567-A1 Benzimidazole Thiophene Compounds GLAXOSMITHKLINE LLC 2008-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005398-A1 Methods For The Treatment of Central Nervous System Tumors TUBB3, TUBB6, TUBB PLK1 424/4885PLK3 1271/4885NEK2 467/4885
US-20080214567-A1 Benzimidazole Thiophene Compounds ABCB1, ABCG2, CYP3A5 PLK1 344/4885PLK3 934/4885NEK2 2296/4885
US-20080249301-A1 Regioselective Process for Preparing Benzimidazole Thiophenes CYP3A4, CYP2C19, CYP2B6 PLK1 1718/4885PLK3 2097/4885NEK2 1915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.